Back
SLR Investment 10K Form
Sell
12
SLRC
SLR Investment
Last Price:
15.19
Seasonality Move:
1.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | SLRC/SLR Investment Quarterly |
2023-11-07 | 10Q | SLRC/SLR Investment Quarterly |
2023-08-08 | 10Q | SLRC/SLR Investment Quarterly |
2023-05-10 | 10Q | SLRC/SLR Investment Quarterly |
2022-11-02 | 10Q | SLRC/SLR Investment Quarterly |
2022-08-02 | 10Q | SLRC/SLR Investment Quarterly |
Receive SLRC News And Ratings
See the #1 stock for the next 7 days that we like better than SLRC
SLRC Financial Statistics
Sales & Book Value
Annual Sales: | $86.54M |
---|---|
Cash Flow: | $2.93M |
Price / Cash Flow: | 9.44 |
Annual Sales: | $18.20 |
Price / Book: | 0.84 |
Profitability
EPS (TTM): | 1.86000 |
---|---|
Net Income (TTM): | $101.67M |
Gross Margin: | $0 |
Return on Equity: | 10.3% |
Return on Assets: | 4.06% |
SLR Investment Earnings Forecast
Key SLR Investment Financial Ratios
- The Gross Profit Margin over the past 8 years for SLRC is 0.00%.
- The Selling, General & Administrative Expenses for SLRC have been equal to 12.31% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 23.03% of Operating Income.
- The Net Earning history of SLRC is 88.27% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 6 years.
SLR Investment Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | SLRC |
CUSIP: | 83413U |
Website: | slrinvestmentcorp.com |
Debt
Debt-to-Equity Ratio: | 1.16 |
---|---|
Current Ratio: | 1.05 |
Quick Ratio: | 1.04 |
Price-to-Earnings
Trailing P/E Ratio: | 10.86 |
---|---|
Forward P/E Ratio: | 9.28 |
SLRC Technical Analysis vs Fundamental Analysis
Sell
12
SLR Investment (SLRC)
is a Sell
Is SLR Investment a Buy or a Sell?
-
SLR Investment stock is rated a Sell
The current SLR Investment [SLRC] share price is $15.20. The Score for SLRC is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.